Exelixis reported $1.66B in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 640.92M 4.81M
Acceleron Pharma XLRN:US $ 696.61M 21.16M
Agios Pharmaceuticals AGIO:US $ 1305.29M 397.28M
Akebia Therapeutics AKBA:US $ 330.08M 0.99M
Amgen AMGN:US $ 24380M 5281M
AstraZeneca AZN:LN 26.69B 583M
Bayer BAYN:GR 31.94B 506M
Biomarin Pharmaceutical BMRN:US $ 2311.57M 46.27M
Bluebird Bio BLUE:US $ 832.32M 71.2M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Cytokinetics CYTK:US $ 494.94M 130.71M
Dicerna Pharmaceuticals DRNA:US $ 589M 27.49M
Eisai 4523:JP Y 570717M 8210M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Esperion Therapeutics ESPR:US $ 170.67M 104.51M
Exelixis EXEL:US $ 1662.03M 68.78M
Genmab GEN:DC 21.95B 1.65B
Glaxosmithkline GSK:US $ 18254M 688M
Immunogen IMGN:US $ 296.8M 22.41M
IONIS PHARMACEUT IONS:US $ 2156M 82.42M
Macrogenics MGNX:US $ 334.7M 32.3M
Mirati Therapeutics MRTX:US $ 1171.89M 106.2M
Moderna Inc MRNA:US 13.42B 2.46B
Nektar Therapeutics NKTR:US $ 986.14M 70.01M
Neurocrine Biosciences NBIX:US $ 1005.7M 104.4M
Novartis NOVN:VX 26.25B 2.45B
Puma Biotechnology PBYI:US $ 136.92M 30.83M
Seattle Genetics SGEN:US $ 3114.61M 16.1M
Takeda 4502:JP Y 2456353M 20105M
Ultragenyx Pharmaceutical RARE:US $ 846.88M 102.61M
Xencor XNCR:US $ 329.63M 151.34M
YTE INCY:US $ 2923.8M 303.74M